Colomer Bosch, Ramon ramon.colomer@uam.es
Actividades
- Artículos 257
- Libros 4
- Capítulos de libro 3
- Congresos 91
- Documentos de trabajo 1
- Informes técnicos 4
- Proyectos de investigación 1
- Tesis dirigidas 9
- Patentes o licencias de software 0
F-18-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial
- Quintela-Fandino, M.
- Lluch, A.
- Manso, L.
- Calvo, I.
- Cortes, J.
- García-Saenz, J.A.
- Gil-Gil, M.
- Martinez-Jánez, N.
- Gonzalez-Martin, A.
- Adrover, E.
- De Andres, R.
- Viñas, G.
- Llombart-Cussac, A.
- Alba, E.
- Guerra, J.
- Bermejo, B.
- Zamora, E.
- Moreno-Anton, F.
- Simon, S.P.
- Carrato, A.
- Lopez-Alonso, A.
- Escudero, M.J.
- Campo, R.
- Carrasco, E.
- Palacios, J.
- Mulero, F.
- Colomer, R.
Clinical Cancer Research (p. 1432-1441) - 15/3/2017
Editor: American Association for Cancer Research Inc.
10.1158/1078-0432.ccr-16-0738 Ver en origen
- ISSN 15573265
- ISSN/ISBN 1557-3265
Strategies to design clinical studies to identify predictive biomarkers in cancer research.
- Perez-Gracia JL, Sanmamed MF, Bosch A, Patiño-Garcia A, Schalper KA, Segura V, Bellmunt J, Tabernero J, Sweeney CJ, Choueiri TK, Martín M, Fusco JP, Rodriguez-Ruiz ME, Calvo A, Prior C, Paz-Ares L, Pio R, Gonzalez-Billalabeitia E, Gonzalez Hernandez A, Páez D, Piulats JM, Gurpide A, Andueza M, de Velasco G, Pazo R, Grande E, Nicolas P, Abad-Santos F, Garcia-Donas J, Castellano D, Pajares MJ, Suarez C, Colomer R, Montuenga LM, Melero I
Cancer Treatment Reviews (p. 79-97) - 1/2/2017
- ISSN 03057372
- iMarina
Advanced breast cancer clinical nursing curriculum: review and recommendations
- C Vila
- Concepción Reñones
- Társila Ferro
- Mª Á Peñuelas
- M del Mar Jiménez
- Á Rodríguez-Lescure
- Montserrat Muñoz
- R Colomer
Clinical & Translational Oncology (p. 251-260) - 1/2/2017
10.1007/s12094-016-1530-0 Ver en origen
- ISSN 1699048X
- iMarina
- iMarina
Critically short telomeres and toxicity of chemotherapy in early breast cancer
- Quintela-Fandino M
- Soberon N
- Lluch A
- Manso L
- Calvo I
- Cortes J
- Moreno-Antón F
- Gil-Gil M
- Martinez-Jánez N
- Gonzalez-Martin A
- Adrover E
- de Andres R
- Viñas G
- Llombart-Cussac A
- Alba E
- Mouron S
- Guerra J
- Bermejo B
- Zamora E
- García-Saenz JA
- Simon SP
- Carrasco E
- Escudero MJ
- Campo R
- Colomer R
- Blasco MA
Oncotarget (p. 21472-21482) - 1/1/2017
- ISSN 19492553
- iMarina
Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents
- Ramon Colomer
- Ariadna Sarrats
- Ruth Lupu
- Teresa Puig
Current Drug Targets (p. 147-159) - 1/1/2017
10.2174/1389450117666160112113930 Ver en origen
- ISSN 13894501
- iMarina
- iMarina
Abstract P4-21-41: Primary analysis of BERENICE: A phase II cardiac safety study of pertuzumab, trastuzumab, and neoadjuvant anthracycline-based chemotherapy in patients with …
- SM Swain
- MS Ewer
- G Viale
- S Delaloge
- JM Ferrero
- M Verrill
- R Colomer
- C Vieira
- TL Werner
- H Douthwaite
- D Bradley
- M Waldron-Lynch
- J Eng-Wong
- C Dang
Cancer Research (p. P4-41) - 1/1/2017
- ISSN 00085472
- iMarina
IsMetastatic Disease the Best Setting for Cost-Effectiveness Studies?
- Ramon Colomer
- Tomás Pascual
- Joan Albanell
Journal Of Clinical Oncology (p. 3226-+) - 10/9/2016
10.1200/jco.2016.68.2534 Ver en origen
- ISSN 0732183X
- iMarina
- iMarina
Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer The NEfERT-T Randomized Clinical Trial
- Awada, Ahmad
- Colomer, Ramon
- Inoue, Kenichi
- Bondarenko, Igor
- Badwe, Rajendra A.
- Demetriou, Georgia
- Lee, Soo-Chin
- Mehta, Ajay O.
- Kim, Sung-Bae
- Bachelot, Thomas
- Goswami, Chanchal
- Deo, Suryanarayan
- Bose, Ron
- Wong, Alvin
- Xu, Feng
- Yao, Bin
- Bryce, Richard
- Carey, Lisa A.;
Jama Oncology (p. 1557-1564) - 1/12/2016
10.1001/jamaoncol.2016.0237 Ver en origen
- ISSN 23742445
Antiangiogenics and hypoxic response: Role of fatty acid synthase inhibitors
- Bueno M
- Sanchez J
- Colomer R
- Quintela-Fandino M
Current Drug Targets (p. 1735-1746) - 1/1/2016
10.2174/1389450117666160502151857 Ver en origen
- ISSN 13894501
- iMarina
- iMarina
Primary analysis of BERENICE: A phase II cardiac safety study of pertuzumab, trastuzumab, and neoadjuvant anthracycline-based chemotherapy in patients with locally advanced …
- Sandra M Swain
- Michael S Ewer
- Giuseppe Viale
- Suzette Delaloge
- Jean Marc Ferrero
- Mark Verrill
- Ramon Colomer
- Cláudia Vieira
- Theresa L Werner
- Hannah Douthwaite
- Denise Bradley
- Maeve Waldron-Lynch
- Jennifer Eng-Wong
- Chau Dang13
Communications Of The Acm - 1/1/2016
- ISSN 00010782
- iMarina
Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated …
- Chau Dang
- Michael S Ewer
- Suzette Delaloge
- Jean-Marc Ferrero
- Mark Verrill
- Ramon Colomer
- Claudia Vieira
- Luis de la Cruz Merino
- Jennifer Lucas
- Theresa L Werner
- Hannah Douthwaite
- Denise Bradley
- Maeve Waldron-Lynch
- Jennifer Eng-Wong
- Sandra M Swain
1/1/2018
- iMarina
Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
- J Rogado
- MD Fenor De La Maza
- V Pacheco-Barcia
- JM Serra
- P Toquero
- B Vera
- A Ballesteros
- R Mondejar
- O Donnay
- B Obispo
- R Colomer
- JM Sanchez-Torres
1/1/2017
- iMarina
Medicina de precisión en oncología: Éxitos y perspectivas bioéticas
- Ramón Colomer Bosch
Bioética Y Cáncer (p. 17-26) - 1/1/2020
- iMarina
Fatty acid metabolism in cancer cell survival: A new anti-cancer target
- Porta, Rut
- Colomer, Ramon
- Puig, Teresa;
Cell Respiration And Cell Survival: Processes, Types And Effects (p. 193-208) - 1/12/2011
- iMarina
Phase IB/II trial of palbociclib and binimetinib in advanced triple-negative breast cancer with hyperactivation of ERK and/or CDK4/6
- Manso, Luis
- Cortes, Alfonso
- Cejalvo, Juan M.
- Morales, Serafin
- Saenz, Jose A. Garcia
- Colomer, Ramon
- Sanchez-Bayona, Rodrigo
- Silva, Jorge
- Guerra, Juan A.
- Malon, Diego
- Mouron, Silvana
- Caleiras, Eduardo
- Quintela-Fandino, Miguel;
Cancer Research - 15/2/2022
10.1158/1538-7445.sabcs21-ot2-19-08 Ver en origen
- ISSN 00085472
Pertuzumab/trastuzumab in early stage HER2-positive breast cancer: 5-year and final analysis of the BERENICE trial
- Dang, C.
- Ewer, M. S.
- Delaloge, S.
- Ferrero, J-M.
- Colomer, R.
- de la Cruz Merino, L.
- Dadswell, K.
- Verrill, M.
- Eiger, D.
- Sarkar, S.
- de Haas, S.
- Restuccia, E.
- Swain, S. M.;
Annals Of Oncology (p. S38-S39) - 1/5/2021
10.1016/j.annonc.2021.03.057 Ver en origen
- ISSN 09237534
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) plus chemotherapy in HER2-positive early breast cancer (EBC): Safety results from the adjuvant phase of the randomised, open-label, multicentre phase III (neo)adjuvant FeDeriCa study
- Im, S-A.
- Tan, A. R.
- Mattar, A.
- Colomer, R.
- Stroyakovskii, D.
- Nowecki, Z.
- De Laurentiis, M.
- Pierga, J-Y.
- Jung, K. H.
- Schem, C.
- Aguila, C.
- Crnjevic, T. Badovinac
- Heeson, S.
- Shivhare, M.
- Alexandrou, A.
- Restuccia, E.
- Jackisch, C.;
Annals Of Oncology (p. S40-S41) - 1/5/2021
10.1016/j.annonc.2021.03.060 Ver en origen
- ISSN 09237534
Immune T-cell subpopulations from the peripheral blood of non-small cell lung cancer patients are associated with the efficacy of anti-PD-1 immunotherapy
- Rogado, J.
- Pozo, F.
- Troule, K.
- Sanchez-Torres, J. M.
- Romero Laorden, N.
- Mondejar Solis, R.
- Donnay Candil, O.
- Ballesteros Garcia, A. I.
- Pacheco-Barcia, V.
- Aspa, J.
- Al-Shahrour, F.
- Alfranca, A.
- Colomer, R.;
Annals Of Oncology (p. S999-S1000) - 1/1/2021
10.1016/j.annonc.2021.08.1889 Ver en origen
- ISSN 09237534
Association of efficacy of anti-PD-1 immunotherapy in patients with advanced cancer with immune-related adverse events (irAEs)
- Rogado Revuelta, Jacobo
- Romero-Laorden, Nuria
- Sanchez Torres, Jose Miguel
- Pacheco-Barcia, Vilma
- Ballesteros, Anabel
- Maria Ramos-Levi, Ana
- Arranz, Reyes
- Lorenzo, Alicia
- Gullon, Pedro
- Garrido Garcia, Ana
- Maria Serra, Jose
- Donnay, Olga
- Adrados, Magdalena
- Costas, Pablo
- Aspa, Javier
- Alfranca, Arantza
- Fenor De la Maza, Maria Dolores
- Mondejar, Rebeca
- Colomer, Ramon;
Journal Of Clinical Oncology - 1/1/2019
- ISSN 0732183X
- iMarina
CONTRIBUTION OF TRASTUZUMAB TO THE PROGNOSTIC IMPROVEMENT OF HER2-POSITIVE EARLY BREAST CANCER IN SPAIN
- Ciruelos, E.
- Alba, E.
- Lopez, R.
- Lluch, A.
- Martin, M.
- Arroyo, I
- Navarro, B.
- Carcedo, D.
- Colomer, R.
- Albanell, J.;
Value In Health (p. S18-S18) - 1/1/2018
10.1016/j.jval.2018.09.102 Ver en origen
- ISSN 10983015
Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated results from the BERENICE study
- Dang, Chau
- Ewer, Michael S.
- Delaloge, Suzette
- Ferrero, Jean-Marc
- Verrill, Mark
- Colomer, Ramon
- Vieira, Claudia
- de la Cruz-Merino, Luis
- Lucas, Jennifer
- Werner, Theresa L.
- Douthwaite, Hannah
- Bradley, Denise
- Waldron-Lynch, Maeve
- Eng-Wong, Jennifer
- Swain, Sandra M.;
Cancer Research - 1/1/2018
- ISSN 00085472
- iMarina
Safety of self-expandable metal stents (SEMS) or emergency surgery for acute colonic obstruction in metastatic colon cancer patients treated with bevacizumab
- Pacheco-Barcia, V.
- Mondejar Solis, R.
- Martinez Saez, O.
- Longo Munoz, F.
- Bermejo, E.
- Moreno Monteagudo, J.
- Marin, C.
- Correa, A.
- Maqueda, R.
- Rogado, J.
- Garcia de Paredes, A.
- Rodriguez de Santiago, E.
- Pachon Olmos, V.
- Ferreiro Monteagudo, R.
- Rodriguez Garrote, M.
- Carrato, A.
- Donnay, O.
- Martin, E.
- Santander, C.
- Colomer, R.;
Annals Of Oncology - 1/1/2018
- ISSN 09237534
- iMarina
The impact of primary tumor location in patients with resected colorectal liver metastasis
- Pacheco-Barcia, V.
- Donnay, O.
- Solis, R. Mondejar
- Serrano, R.
- Martin, E.
- del Campo, L.
- Rogado, J.
- Vera, B.
- Ballesteros, A.
- Colomer, R.;
Annals Of Oncology - 1/1/2018
- ISSN 09237534
- iMarina
Gemcitabine plus nab-paclitaxel versus modified FOLFIRINOX as first line chemotherapy in metastatic pancreatic cancer: A comparison of toxicity and survival
- V Pacheco-Barcia
- T France
- G Zogopoulos
- N Bouganim
- O Donnay
- T Alcindor
- R Mondéjar Solís
- K Guo
- E Martin
- R Colomer
- J Asselah
Annals Of Oncology (p. mdy151. 163-mdy151. 163) - 1/1/2018
- ISSN 09237534
- iMarina
[Generalized cutaneous-nodal metastatic spread as initial manifestation of the recurrence of a gastric adenocarcinoma]
- Sanchez-Munoz, A
- Gravalos Castro, C
- Colomer Bosch, R
- Garcia Velasco, A
- Garcia, J P
- Cortes-Funes, H
Revista Clinica Espanola (p. 597-598) - 1/1/2003
- ISSN 15781860
- iMarina
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
- Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P, monarchE Committee Members and Investigators
Journal Of Clinical Oncology (p. 3987-3998) - 1/12/2020
- ISSN 0732183X
- iMarina
A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancer
- Antón A, Hornedo J, Lluch A, Massuti B, Corral M, Colomer R
Clinical Breast Cancer (p. 286-91) - 1/1/2003
10.3816/cbc.2003.n.034 Ver en origen
- ISSN 15268209
Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization
- Arranz, R.
- García-Alfonso, P.
- Sobrino, P.
- Zamora, P.
- Carrión, R.
- García-Laraña, J.
- Pérez, G.
- López, J.
- Lavilla, E.
- Lozano, M.
- Rayón, C.
- Colomer, R.
- González Barón, M.
- Flores, E.
- Pérez-Manga, G.
- Fernández-Rañada, J.M.
Journal Of Clinical Oncology (p. 1538-1546) - 1/1/1998
Editor: American Society of Clinical Oncology
10.1200/jco.1998.16.4.1538 Ver en origen
- ISSN 0732183X
- ISSN/ISBN 0732-183X
- Dialnet
- iMarina
Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.
- Hitt, R
- Paz-Ares, L
- Hidalgo, M
- Colomer, R
- Brandariz, A
- Pena, M
- Alvarez-Vicent, J
- Hornedo, J
- Cortes-Funes, H;
Seminars In Oncology (p. S19-20) - 1/12/1997
- ISSN 00937754
- iMarina
Índice de Respuesta Inflamatoria Sistémica (IRIS): Factor Pronóstico en el Cáncer de Páncreas
- Rebeca Mondéjar Solís (Director)
- Ramón Colomer Bosch (Director) Doctorando: Pacheco Barcia, Vilma Emilia
28/1/2021
- iMarina
Cambios en el perfil inmunohistoquímico tras tratamiento neoadyuvante en pacientes con cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Miguel Martín Giménez (Director) Doctorando: Rebeca Mondéjar Solís
1/1/2016
- iMarina
El fenotipo basal-her2 en el cáncer de mama: caracterización clínico-molecular e implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Javier Abel Menéndez Menéndez (Director)
- Ramón Colomer Bosch (Director) Doctorando: Begoña Martín Castillo
1/1/2016
- iMarina
Efectos de la inhibición de la síntesis de ácidos grasos en la eficacia de los tratamientos antineoplásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Alejandro Vázquez Martín
1/1/2007
- iMarina
Estudio fase i/ii con dosis altas de mitoxantrone y ciclofosfamida sin soporte hematopoyético para el tratamiento de tumores de alto riesgo y metastásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: José Luis Pérez Gracia
1/1/2004
- iMarina
Características y evolución del cáncer de mama metástásico al diagnóstico: comparación con las recidivas del cáncer de mama inicialmente localizado
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: Antonio Jimeno Largo
1/1/2003
- iMarina
Importancia de la dosis de antraciclinas en el tratamiento adyuvante del cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca Lorente (Director) Doctorando: María Luz Amador Muñoz
1/1/2002
- iMarina
Ácidos grasos en la progresión del cáncer de mama: implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Javier Abel Menéndez Menéndez
1/1/2001
- iMarina
Utilidad de la expresión de p53 en tumores de mama como factor pronóstico y predictor de la respuesta al tratamiento
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Cecilia Guzman Zapater
1/1/1996
- iMarina
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Publons
-
Scopus Author ID
-
Dialnet id